Liise-AnnePirofskiMD
Infectious Disease • Bronx, NYProfessor, Medicine, A Einstein College of Medicine of Yeshiva Univ
Are you Dr. Pirofski?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 51 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Weiler Dept of Medicine
1825 Eastchester Road
Bronx, NY 10467Phone+1 718-430-2372Fax+1 718-430-8968
Summary
- Dr. Liise-Anne Pirofski, MD is an infectious disease specialist in Bronx, New York. She is currently licensed to practice medicine in New York. She is affiliated with Montefiore Medical Center and is a Professor at A Einstein College of Medicine of Yeshiva Univ.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1985 - 1989
NYU Grossman School of MedicineResidency, Internal Medicine, 1982 - 1985
Albert Einstein College of MedicineClass of 1982
Certifications & Licensure
NY State Medical License 1984 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients Start of enrollment: 2020 Apr 17
Publications & Presentations
PubMed
- 1 citationsSingle Monoclonal Antibodies Should Not Be Used for COVID-19 Therapy: A Call for Antiviral Stewardship.Arturo Casadevall, Daniele Focosi, Liise-Anne Pirofski, Shmuel Shoham
Clinical Infectious Diseases. 2024-12-17 - 3 citationsConvalescent plasma and predictors of mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis.Massimo Franchini, Mario Cruciani, Carlo Mengoli, Arturo Casadevall, Claudia Glingani
Clinical Microbiology and Infection. 2024-12-01 - Serotype 3 Streptococcus pneumoniae Escapes the Immune Responses Induced by PCV13 in Mice With High Susceptibility to Infection.Giuliana S Oliveira, Johanna Rivera, Tasson C Rodrigues, Giovanna B Carneiro, Orlando G Ribeiro
Immunity, Inflammation and Disease. 2024-12-01
Authored Content
- A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful SignalsJune 2020
Grant Support
- B Cell Subsets And Immunity To CryptococcosisNational Institute Of Allergy And Infectious Diseases2012
- Variable Gene Use And Pneumococcal Immunity In AIDSNational Institute Of Allergy And Infectious Diseases2004–2010
- Variable Gene Defects And Pneumococcal SusceptibilityNational Institute Of Allergy And Infectious Diseases2004–2010
- Human Antibodies To Cryptococcus NeoformansNational Institute Of Allergy And Infectious Diseases2005–2009
- Human Antibodies To Crytococcus NeoformansNational Institute Of Allergy And Infectious Diseases2006
- Variable Gene Defects And Pneumococcal SusceptibilityNational Institute Of Allergy And Infectious Diseases2001–2003
- Variable Gene Use And Pneumococcal Immunity In AIDSNational Institute Of Allergy And Infectious Diseases2000–2003
- Human Antibodies To Cryptococcus NeoformansNational Institute Of Allergy And Infectious Diseases1994–2003
- Antibody Structure In Adenovirus InfectionNational Institute Of Allergy And Infectious Diseases1988–1992
Professional Memberships
- Member
